ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Xilio Therapeutics Inc

Xilio Therapeutics Inc (XLO)

0,9085
-0,0242
(-2,59%)
Geschlossen 08 März 10:00PM
0,925
0,0165
(1,82%)
Nach Börsenschluss: 1:23AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,925
Gebot
0,85
Fragen
2,25
Volumen
590.913
0,8521 Tagesbereich 0,9595
0,58 52-Wochen-Bereich 1,93
Marktkapitalisierung
Handelsende
0,9327
Handelsbeginn
0,9357
Letzter Handelszeitpunkt
Finanzvolumen
US$ 537.757
VWAP
0,910045
Durchschnittliches Volumen (3 Mio.)
4.494.960
Ausgegebene Aktien
43.958.074
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,52
Gewinn pro Aktie (EPS)
-1,74
Erlöse
-
Nettogewinn
-76,4M

Über Xilio Therapeutics Inc

Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immuno... Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. The goal is to overcome the limitations of current I-O therapies by developing products with an improved therapeutic index. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Xilio Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XLO. The last closing price for Xilio Therapeutics was US$0,93. Over the last year, Xilio Therapeutics shares have traded in a share price range of US$ 0,58 to US$ 1,93.

Xilio Therapeutics currently has 43.958.074 shares in issue. The market capitalisation of Xilio Therapeutics is US$41,00 million. Xilio Therapeutics has a price to earnings ratio (PE ratio) of -0.52.

XLO Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0374.166666666670.8880.97990.8100014983510.90472952CS
40.23534.05797101450.691.70.6315114287561.39956009CS
12-0.085-8.415841584161.011.70.6344949601.36369184CS
260.117814.59365708620.80721.70.6321082361.34422878CS
520.0353.932584269660.891.930.5814100051.3048CS
156-7.655-89.21911421918.589.590.495143491.38547581CS
260-14.075-93.83333333331527.950.494705551.73905063CS

XLO - Frequently Asked Questions (FAQ)

What is the current Xilio Therapeutics share price?
The current share price of Xilio Therapeutics is US$ 0,925
How many Xilio Therapeutics shares are in issue?
Xilio Therapeutics has 43.958.074 shares in issue
What is the market cap of Xilio Therapeutics?
The market capitalisation of Xilio Therapeutics is USD 41M
What is the 1 year trading range for Xilio Therapeutics share price?
Xilio Therapeutics has traded in the range of US$ 0,58 to US$ 1,93 during the past year
What is the PE ratio of Xilio Therapeutics?
The price to earnings ratio of Xilio Therapeutics is -0,52
What is the reporting currency for Xilio Therapeutics?
Xilio Therapeutics reports financial results in USD
What is the latest annual profit for Xilio Therapeutics?
The latest annual profit of Xilio Therapeutics is USD -76,4M
What is the registered address of Xilio Therapeutics?
The registered address for Xilio Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Xilio Therapeutics website address?
The website address for Xilio Therapeutics is xiliotx.com
Which industry sector does Xilio Therapeutics operate in?
Xilio Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ABLVAble View Global Inc
US$ 1,73
(137,18%)
5,14M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
DWTXDogwood Therapeutics Inc
US$ 6,63
(49,66%)
25,92M
KZIAKazia Therapeutics Ltd
US$ 1,1899
(40,80%)
4,5M
ALBTAvalon GloboCare Corporation
US$ 6,96
(-36,15%)
577,55k
SCNXScienture Holdings Inc
US$ 1,55
(-35,68%)
1,59M
ACXPAcurx Pharmaceuticals Inc
US$ 0,4572
(-29,88%)
1,18M
RETOReTo Eco Solutions Inc
US$ 5,42
(-27,73%)
108,27k
OCTOEightco Holdings Inc
US$ 1,08
(-27,03%)
336,99k
BTOGBit Origin Ltd
US$ 0,6117
(118,46%)
622,67M
SUNESUNation Energy Inc
US$ 0,402999
(127,55%)
482,05M
NVDANVIDIA Corporation
US$ 112,69
(1,92%)
341,94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,675
(-0,70%)
143,04M
ICONIcon Energy Corporation
US$ 0,169898
(17,17%)
142,23M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock